Sickle cell disease affects approximately 100,000 people in the US and is most common in African Americans. The Food and Drug Administration (FDA) has approved Casgevy and Lyfgenia, the first ...

The investigational agent was designed to reduce the gastrointestinal side effects observed with galantamine. The Food and Drug Administration (FDA) has accepted for review the New Drug Application ...

The combination of metronomic chemotherapy and PD-1 blockade has demonstrated efficacy in patients with breast cancer, according to research presented at the San Antonio Breast Cancer Symposium 2023.

Credit: Becton, Dickinson and Company. The system consists of a capillary blood collection tube and a finger sleeve that is intended for use by a trained health care provider, without the need of a ...

Credit: Mosie Baby. The Mosie Baby At-Home Insemination Kit is available for $129.99. The Food and Drug Administration (FDA) has cleared the Mosie Baby Kit for over-the-counter (OTC) home use by ...

Credit: Eli Lilly. Zepbound contains tirzepatide, a glucose-dependent insulinotropic polypeptide receptor and glucagon-like peptide-1 receptor agonist. The most common adverse reactions reported with ...

To date, there have been no reports of serious injury associated with this issue. Baxter International has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump due to ...

At 24 months, 97% of the 316 participants still enrolled in the trial retained neutralizing antibody titers above the seroresponse threshold after a single dose of Ixchiq. Antibody levels remained ...

Safety alert issued for serious reactions to certain seizure drugs; drug approved to treat a rare form of tumor; T-cell malignancies reported with cell immunotherapies; organ transplant rejection ...

Credit: Novartis. The approval was based on data from the phase 3 APPLY-PNH trial. Health care providers who prescribe Fabhalta must enroll in the Fabhalta REMS. The Food and Drug Administration (FDA) ...

VT-X7 is a drug/device combination product designed to deliver therapeutic concentrations of vancomycin and tobramycin directly to the joint space and surrounding tissue. The Food and Drug ...

Reports of T-cell malignancies with serious outcomes including hospitalization and death were received from clinical trials and postmarketing adverse event data. The Food and Drug Administration ...